Chemokines and atherosclerosis.
暂无分享,去创建一个
[1] B. Rollins,et al. Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[2] F. Luscinskas,et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.
[3] P. Murphy,et al. Differential effects of leukotactin-1 and macrophage inflammatory protein-1 alpha on neutrophils mediated by CCR1. , 1999, Journal of immunology.
[4] N. Maeda,et al. Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. , 1999, Atherosclerosis.
[5] K. Preissner,et al. Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[6] K. Burnand,et al. Expression and cellular localization of the CC chemokines PARC and ELC in human atherosclerotic plaques. , 1999, The American journal of pathology.
[7] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[8] A. Zlotnik,et al. Recent advances in chemokines and chemokine receptors. , 1999, Critical reviews in immunology.
[9] O. Quehenberger,et al. Chemokine receptor CCR2 expression and monocyte chemoattractant protein-1-mediated chemotaxis in human monocytes. A regulatory role for plasma LDL. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[10] R. Alexander,et al. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. , 1998, Circulation research.
[11] C. Power,et al. Definition, function and pathophysiological significance of chemokine receptors. , 1998, Trends in pharmacological sciences.
[12] S. Bhakdi,et al. Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[13] I. Charo,et al. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.
[14] P. Libby,et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.
[15] P. Libby,et al. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. , 1998, Trends in cardiovascular medicine.
[16] H. Nomiyama,et al. EBI1-ligand chemokine (ELC) attracts a broad spectrum of lymphocytes: activated T cells strongly up-regulate CCR7 and efficiently migrate toward ELC. , 1998, International immunology.
[17] O. Yoshie,et al. Identification of Single C Motif-1/Lymphotactin Receptor XCR1* , 1998, The Journal of Biological Chemistry.
[18] J. Harrison,et al. Expression of CCR5 Increases during Monocyte Differentiation and Directly Mediates Macrophage Susceptibility to Infection by Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[19] M. Baggiolini,et al. HCC-2, a human chemokine: gene structure, expression pattern, and biological activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[21] P. Libby,et al. CD40 signaling in vascular cells: a key role in atherosclerosis? , 1998, Atherosclerosis.
[22] C. Mackay,et al. Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes , 1998, The Journal of experimental medicine.
[23] A. Roach,et al. Human vascular smooth muscle cells express receptors for CC chemokines. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[24] H. Gabbert,et al. Immunohistochemical demonstration of enzymatically modified human LDL and its colocalization with the terminal complement complex in the early atherosclerotic lesion. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[25] E. Ohlstein,et al. Chemokine Receptors in Human Endothelial Cells , 1998, The Journal of Biological Chemistry.
[26] A. Luster,et al. Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.
[27] W. Erl,et al. Monocytic cell adhesion to endothelial cells stimulated by oxidized low density lipoprotein is mediated by distinct endothelial ligands. , 1998, Atherosclerosis.
[28] R. Strieter,et al. The role of CXC chemokines in the regulation of angiogenesis in association with lung cancer. , 1998, Trends in cardiovascular medicine.
[29] E. Butcher,et al. Chemokines and the arrest of lymphocytes rolling under flow conditions. , 1998, Science.
[30] R. Terkeltaub,et al. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. , 1998, The Journal of clinical investigation.
[31] M. Volin,et al. Chemokine receptor CXCR4 expression in endothelium. , 1998, Biochemical and biophysical research communications.
[32] S. Su,et al. Chemokines, receptors, and their role in cardiovascular pathology , 1998, International journal of clinical & laboratory research.
[33] R. Nibbs,et al. Cloning and Characterization of a Novel Promiscuous Human β-Chemokine Receptor D6* , 1997, The Journal of Biological Chemistry.
[34] D. H. Park,et al. Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. , 1997, Journal of immunology.
[35] G. McFadden,et al. New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road. , 1997, Biochemical pharmacology.
[36] James J. Campbell,et al. Multistep Navigation and the Combinatorial Control of Leukocyte Chemotaxis , 1997, The Journal of cell biology.
[37] R. Bravo,et al. Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor , 1997, The Journal of experimental medicine.
[38] Robert V Farese,et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.
[39] T. Schall,et al. Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and Adhesion , 1997, Cell.
[40] K. Ley,et al. Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[41] D. Steiner,et al. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. , 1997, DNA and cell biology.
[42] A. Roach,et al. Chemokine production by human vascular smooth muscle cells: modulation by IL‐13 , 1997, British journal of pharmacology.
[43] G. Hansson. Cell-mediated immunity in atherosclerosis , 1997, Current opinion in lipidology.
[44] M. Peitsch,et al. Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines. , 1997, European journal of biochemistry.
[45] A. Becker,et al. Costimulatory molecules in human atherosclerotic plaques: an indication of antigen specific T lymphocyte activation. , 1997, Atherosclerosis.
[46] M. Ridanpää,et al. Molecular Cloning of a Novel Human CC Chemokine Secondary Lymphoid-Tissue Chemokine That Is a Potent Chemoattractant for Lymphocytes and Mapped to Chromosome 9p13* , 1997, The Journal of Biological Chemistry.
[47] Y. Sakaki,et al. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. , 1997, Journal of immunology.
[48] T. Warner,et al. Monocyte chemotactic protein-1 expression is associated with the development of vein graft intimal hyperplasia. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[49] E. Hurt-Camejo,et al. Potential involvement of type II phospholipase A2 in atherosclerosis. , 1997, Atherosclerosis.
[50] H. Sarau,et al. Cloning, in Vitro Expression, and Functional Characterization of a Novel Human CC Chemokine of the Monocyte Chemotactic Protein (MCP) Family (MCP-4) That Binds and Signals through the CC Chemokine Receptor 2B* , 1997, The Journal of Biological Chemistry.
[51] T. Mcclanahan,et al. A dendritic-cell-derived C–C chemokine that preferentially attracts naive T cells , 1997, Nature.
[52] H. Nomiyama,et al. Molecular Cloning of a Novel Human CC Chemokine EBI1-ligand Chemokine That Is a Specific Functional Ligand for EBI1, CCR7* , 1997, The Journal of Biological Chemistry.
[53] K. Murao,et al. Regulation of Expression of the Human Monocyte Chemotactic Protein-1 Receptor (hCCR2) by Cytokines* , 1997, The Journal of Biological Chemistry.
[54] P. Libby,et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Farber. Mig and IP‐10: CXC chemokines that target lymphocytes , 1997, Journal of leukocyte biology.
[56] Osamu Yoshie,et al. Molecular Cloning of a Novel Human CC Chemokine Liver and Activation-regulated Chemokine (LARC) Expressed in Liver , 1997, The Journal of Biological Chemistry.
[57] K. Chung,et al. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids. , 1997, Journal of immunology.
[58] H. Nomiyama,et al. Assignment of the human CC chemokine gene TARC (SCYA17) to chromosome 16q13. , 1997, Genomics.
[59] Wei Wang,et al. A new class of membrane-bound chemokine with a CX3C motif , 1997, Nature.
[60] S. J. Myers,et al. Organization and Differential Expression of the Human Monocyte Chemoattractant Protein 1 Receptor Gene , 1997, The Journal of Biological Chemistry.
[61] B Dewald,et al. Human chemokines: an update. , 1997, Annual review of immunology.
[62] M. Reale,et al. Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. , 1997, Journal of vascular research.
[63] Q. Hamid,et al. Human monocyte chemoattractant protein (MCP)-4 is a novel CC chemokine with activities on monocytes, eosinophils, and basophils induced in allergic and nonallergic inflammation that signals through the CC chemokine receptors (CCR)-2 and -3. , 1996, Journal of immunology.
[64] P. Huie,et al. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[65] T. Yue,et al. Interferon-inducible Protein-10 Involves Vascular Smooth Muscle Cell Migration, Proliferation, and Inflammatory Response* , 1996, The Journal of Biological Chemistry.
[66] M. Dorf,et al. Beta-chemokine TCA3 binds to and activates rat vascular smooth muscle cells. , 1996, Journal of immunology.
[67] P. Norman,et al. Monocyte chemoattractant protein‐1 gene expression in injured pig artery coincides with early appearance of infiltrating monocyte/macrophages , 1996, Journal of cellular biochemistry.
[68] O. Yoshie,et al. Molecular Cloning of a Novel T Cell-directed CC Chemokine Expressed in Thymus by Signal Sequence Trap Using Epstein-Barr Virus Vector* , 1996, The Journal of Biological Chemistry.
[69] P. Tipping,et al. Interleukin-8 production by macrophages from atheromatous plaques. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[70] T. Shimokama,et al. Inflammatory and immunological nature of atherosclerosis. , 1996, International journal of cardiology.
[71] P. Murphy. Chemokine receptors: structure, function and role in microbial pathogenesis. , 1996, Cytokine & growth factor reviews.
[72] H. Maegawa,et al. Lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. , 1996, Metabolism: clinical and experimental.
[73] R. Sayers,et al. Angiogenesis in abdominal aortic aneurysms. , 1996, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[74] B. Dewald,et al. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin , 1996, The Journal of experimental medicine.
[75] A. Tall,et al. Interleukin 8 Is Induced by Cholesterol Loading of Macrophages and Expressed by Macrophage Foam Cells in Human Atheroma (*) , 1996, The Journal of Biological Chemistry.
[76] A. Weyrich,et al. Activated platelets signal chemokine synthesis by human monocytes. , 1996, The Journal of clinical investigation.
[77] P. Proost,et al. The role of chemokines in inflammation , 1996, International journal of clinical & laboratory research.
[78] G. Hansson,et al. Immunological mechanisms in atherosclerosis , 1995, Journal of internal medicine.
[79] Armen B. Shanafelt,et al. The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis (*) , 1995, The Journal of Biological Chemistry.
[80] J. Inazawa,et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. , 1995, Genomics.
[81] T. Schall,et al. Molecular cloning and functional characterization of human lymphotactin. , 1995, Journal of immunology.
[82] J. Witztum,et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[83] U. Ikeda,et al. Monocyte chemoattractant protein 1 inhibits growth of rat vascular smooth muscle cells. , 1995, The American journal of physiology.
[84] D. Taub,et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. , 1995, The Journal of clinical investigation.
[85] T. Schall,et al. Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-gamma plus TNF-alpha and inhibition by IL-4 and IL-13. , 1995, Journal of immunology.
[86] T. Fan,et al. Controlling the vasculature: angiogenesis, anti-angiogenesis and vascular targeting of gene therapy. , 1995, Trends in pharmacological sciences.
[87] D. Taub,et al. Modulation of IL‐8 receptor expression on purified human T lymphocytes is associated with changed chemotactic responses to IL‐8 , 1995, Journal of leukocyte biology.
[88] B. Dewald,et al. Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytes , 1995 .
[89] D. Graves,et al. Chemokines, a family of chemotactic cytokines. , 1995, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[90] T. Schall,et al. Chemokines, leukocyte trafficking, and inflammation. , 1994, Current opinion in immunology.
[91] R. Strieter,et al. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-gamma. , 1994, The American journal of pathology.
[92] S M Schwartz,et al. Angiogenesis in human coronary atherosclerotic plaques. , 1994, The American journal of pathology.
[93] M. Gimbrone,et al. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. , 1994, The Journal of clinical investigation.
[94] T. Yue,et al. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells. , 1994, Circulation research.
[95] S Chien,et al. Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[96] R. Horuk. Molecular properties of the chemokine receptor family. , 1994, Trends in pharmacological sciences.
[97] T. Springer,et al. Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[98] Cord Sunderkötter,et al. Macrophages and angiogenesis , 1994, Journal of leukocyte biology.
[99] C. Janeway,et al. Signals and signs for lymphocyte responses , 1994, Cell.
[100] T. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.
[101] T. Schall,et al. Local expression of inflammatory cytokines in human atherosclerotic plaques. , 1994, Journal of atherosclerosis and thrombosis.
[102] A. Becker,et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.
[103] R. Terkeltaub,et al. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[104] R. Ross,et al. Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. , 1993, The American journal of pathology.
[105] C. Chang,et al. Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment. , 1993, Biochimica et biophysica acta.
[106] W. Pearce,et al. Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. , 1993, The American journal of pathology.
[107] E. Leonard,et al. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. , 1993, Human pathology.
[108] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[109] D. Taub,et al. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta , 1993, Science.
[110] G. Bondjers,et al. Endothelial integrity and injury in atherogenesis. , 1993, Transplantation proceedings.
[111] R. Ross,et al. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. , 1993, British heart journal.
[112] R. Strieter,et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.
[113] A. J. Valente,et al. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[114] G. Hansson,et al. T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.
[115] B. Rollins,et al. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. , 1992, Circulation research.
[116] E. Butcher. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity , 1991, Cell.
[117] G. Hansson,et al. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[118] S. Coughlin,et al. Monocyte chemoattractant protein-1 in human atheromatous plaques. , 1991, The Journal of clinical investigation.
[119] H. Rus,et al. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. , 1991, Atherosclerosis.
[120] D. Steinberg,et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[121] D. Goeddel,et al. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES , 1990, Nature.
[122] A. J. Valente,et al. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[123] M. Baggiolini,et al. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.
[124] G. Hansson,et al. Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.
[125] J. Shabanowitz,et al. Complete amino acid sequence of a human monocyte chemoattractant, a putative mediator of cellular immune reactions. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[126] G. Bondjers,et al. Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.
[127] J L Witztum,et al. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. , 1984, Proceedings of the National Academy of Sciences of the United States of America.